These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
555 related articles for article (PubMed ID: 34108040)
1. CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer. Zhu J; Cai T; Zhou J; Du W; Zeng Y; Liu T; Fu Y; Li Y; Qian Q; Yang XH; Li Q; Huang JA; Liu Z J Exp Clin Cancer Res; 2021 Jun; 40(1):192. PubMed ID: 34108040 [TBL] [Abstract][Full Text] [Related]
2. Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis. Wu Z; Jiao M; Shu C; Zhang S; Wang J; Pu J; Zhu J; Zeng Y; Zhu Y; Liu Z Cell Commun Signal; 2024 Jun; 22(1):313. PubMed ID: 38844957 [TBL] [Abstract][Full Text] [Related]
3. EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells. Cai T; Zhou J; Zeng Y; Du W; Zhang Y; Liu T; Fu Y; Huang JA; Qian Q; Zhu J; Ling C; Liu Z J Exp Clin Cancer Res; 2020 May; 39(1):84. PubMed ID: 32393392 [TBL] [Abstract][Full Text] [Related]
4. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation. Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094 [No Abstract] [Full Text] [Related]
5. CD151 promotes cancer cell metastasis via integrins α3β1 and α6β1 in vitro. Fei Y; Wang J; Liu W; Zuo H; Qin J; Wang D; Zeng H; Liu Z Mol Med Rep; 2012 Dec; 6(6):1226-30. PubMed ID: 23007325 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN. Wang H; Guan X; Tu Y; Zheng S; Long J; Li S; Qi C; Xie X; Zhang H; Zhang Y J Exp Clin Cancer Res; 2015 Jun; 34(1):59. PubMed ID: 26063204 [TBL] [Abstract][Full Text] [Related]
7. Knockdown of cathepsin B and uPAR inhibits CD151 and α3β1 integrin-mediated cell adhesion and invasion in glioma. Rao Malla R; Gopinath S; Alapati K; Gorantla B; Gondi CS; Rao JS Mol Carcinog; 2013 Oct; 52(10):777-90. PubMed ID: 22495828 [TBL] [Abstract][Full Text] [Related]
8. Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression. Zang X; Gu J; Zhang J; Shi H; Hou S; Xu X; Chen Y; Zhang Y; Mao F; Qian H; Zhu T; Xu W; Zhang X Cell Death Dis; 2020 Apr; 11(4):215. PubMed ID: 32242003 [TBL] [Abstract][Full Text] [Related]
9. The CD9/CD81 tetraspanin complex and tetraspanin CD151 regulate α3β1 integrin-dependent tumor cell behaviors by overlapping but distinct mechanisms. Gustafson-Wagner E; Stipp CS PLoS One; 2013; 8(4):e61834. PubMed ID: 23613949 [TBL] [Abstract][Full Text] [Related]
10. circRACGAP1 promotes non-small cell lung cancer proliferation by regulating miR-144-5p/CDKL1 signaling pathway. Lu M; Xiong H; Xia ZK; Liu B; Wu F; Zhang HX; Hu CH; Liu P Cancer Gene Ther; 2021 Apr; 28(3-4):197-211. PubMed ID: 32778770 [TBL] [Abstract][Full Text] [Related]
11. SRPX2 promotes cell proliferation and invasion via activating FAK/SRC/ERK pathway in non-small cell lung cancer. Li X; Liu J; Sun H; Zou Y; Chen J; Chen Y; Chen C; Wu X Acta Biochim Pol; 2020 Jun; 67(2):165-172. PubMed ID: 32550700 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p. Jing H; Xia H; Qian M; Lv X Biomed Pharmacother; 2019 Feb; 110():825-833. PubMed ID: 30554121 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway. Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431 [TBL] [Abstract][Full Text] [Related]
14. CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion. Zhou P; Erfani S; Liu Z; Jia C; Chen Y; Xu B; Deng X; Alfáro JE; Chen L; Napier D; Lu M; Huang JA; Liu C; Thibault O; Segal R; Zhou BP; Kyprianou N; Horbinski C; Yang XH Oncotarget; 2015 Oct; 6(30):29675-93. PubMed ID: 26377974 [TBL] [Abstract][Full Text] [Related]
15. CD151 promotes α3β1 integrin-dependent organization of carcinoma cell junctions and restrains collective cell invasion. Zevian SC; Johnson JL; Winterwood NE; Walters KS; Herndon ME; Henry MD; Stipp CS Cancer Biol Ther; 2015; 16(11):1626-40. PubMed ID: 26418968 [TBL] [Abstract][Full Text] [Related]
16. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway. Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760 [TBL] [Abstract][Full Text] [Related]
17. FoxO3a inhibiting expression of EPS8 to prevent progression of NSCLC: A new negative loop of EGFR signaling. Wen Q; Jiao X; Kuang F; Hou B; Zhu Y; Guo W; Sun G; Ba Y; Yu D; Wang D; Zhang F; Qiao HC; Wang S; Tang S; Qiao H EBioMedicine; 2019 Feb; 40():198-209. PubMed ID: 30738830 [TBL] [Abstract][Full Text] [Related]
18. LncRNA EPIC1 promotes tumor angiogenesis via activating the Ang2/Tie2 axis in non-small cell lung cancer. Hou Y; Jia H; Cao Y; Zhang S; Zhang X; Wei P; Xie J; Dong W; Wang B Life Sci; 2021 Feb; 267():118933. PubMed ID: 33359744 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion. Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927 [TBL] [Abstract][Full Text] [Related]
20. CD151-α3β1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling. Baldwin LA; Hoff JT; Lefringhouse J; Zhang M; Jia C; Liu Z; Erfani S; Jin H; Xu M; She QB; van Nagell JR; Wang C; Chen L; Plattner R; Kaetzel DM; Luo J; Lu M; West D; Liu C; Ueland FR; Drapkin R; Zhou BP; Yang XH Oncotarget; 2014 Dec; 5(23):12203-17. PubMed ID: 25356755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]